Vaccine Strategies to Elicit Mucosal Immunity
Vaccines · 13.02.2024 · 12 (2) · 191
DOI: 10.3390/vaccines12020191 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vaccines, online erschienen am 13.02.2024. Verfasst von Yufeng Song und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Virginia, Charlottesville, VA 22908, USA. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 331 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, the Manning Fund for COVID-19 Research at UVA, the Ivy Foundation.
Abstract (Originalsprache)
Vaccines are essential tools to prevent infection and control transmission of infectious diseases that threaten public health. Most infectious agents enter their hosts across mucosal surfaces, which make up key first lines of host defense against pathogens. Mucosal immune responses play critical roles in host immune defense to provide durable and better recall responses. Substantial attention has been focused on developing effective mucosal vaccines to elicit robust localized and systemic immune responses by administration via mucosal routes. Mucosal vaccines that elicit effective immune responses yield protection superior to parenterally delivered vaccines. Beyond their valuable immunogenicity, mucosal vaccines can be less expensive and easier to administer without a need for injection materials and more highly trained personnel. However, developing effective mucosal vaccines faces many challenges, and much effort has been directed at their development. In this article, we review the history of mucosal vaccine development and present an overview of mucosal compartment biology and the roles that mucosal immunity plays in defending against infection, knowledge that has helped inform mucosal vaccine development. We explore new progress in mucosal vaccine design and optimization and novel approaches created to improve the efficacy and safety of mucosal vaccines.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of Virginia, Charlottesville, VA 22908, USA.
- Department of Microbiology, Immunology, and Cancer Biology, University of Virginia, Charlottesville, VA 22908, USA.
Förderung
- NIAID NIH HHS
- the Manning Fund for COVID-19 Research at UVA
- the Ivy Foundation
- the Pendleton Laboratory Fund for Pediatric Infectious Disease Research
- the Coulter Foundation
- NIAID, NIH
- the Commonwealth Commercialization Fund, Virginia Innovation Partnership Corporation
Zitieren
APA
Song, Y., Mehl, F., & Zeichner, S. L. (2024). Vaccine Strategies to Elicit Mucosal Immunity. Vaccines, 12(2), 191. https://doi.org/10.3390/vaccines12020191
Vancouver
Song Y, Mehl F, Zeichner SL. Vaccine Strategies to Elicit Mucosal Immunity. Vaccines. 2024;12(2):191. doi:10.3390/vaccines12020191
BibTeX
@article{Song2024,
author = {Song, Yufeng and Mehl, Frances and Zeichner, Steven L},
title = {Vaccine Strategies to Elicit Mucosal Immunity},
journal = {Vaccines},
year = {2024},
volume = {12},
number = {2},
pages = {191},
doi = {10.3390/vaccines12020191}
}
EUVIMED